Medicare Enrolled
Dr. Kelly McCann, M.D., PH.D.
Internal Medicine · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCann
Dr. Kelly McCann is an internal medicine specialist in San Diego, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. McCann performed 9,144 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McCann received a total of $208,506 from 20 pharmaceutical and/or device companies across 381 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 3% volume in CA
$208,506 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,144
Medicare services
Top 3% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $92 |
| Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 680 | $14 | $445 |
| Anti-nausea injection (ondansetron/Zofran) | 608 | $0 | $11 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
502 | $0 | $5 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
222 | $150 | $960 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
186 | $8 | $58 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
169 | $0 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
165 | $101 | $680 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
161 | $12 | $122 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
132 | $14 | $245 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $100 | $858 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
98 | $119 | $1,090 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
81 | $7 | $487 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
78 | $19 | $150 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
76 | $60 | $384 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
70 | $26 | $475 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
65 | $31 | $267 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $149 | $1,320 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
45 | $1 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
41 | $8 | $25 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
40 | $61 | $620 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
40 | $2 | $25 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
38 | $99 | $534 |
| New patient office visit, complex (60-74 min) | 34 | $182 | $1,360 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
29 | $11 | $225 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
29 | $1 | $13 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
23 | $1 | $15 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
19 | $30 | $297 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.7% high complexity
83.6% medium
9.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$208,506
Total received (2018-2024)
Avg $29,787/year across 7 years
Top 1% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
381
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$36,442
2023
$36,731
2022
$16,927
2021
$5,009
2020
$14,839
2019
$55,239
2018
$43,321
Payments by company (2024)
Lilly USA, LLC
$19,297
Stemline Therapeutics Inc.
$5,560
Novartis Pharmaceuticals Corporation
$4,740
TerSera Therapeutics LLC
$4,556
AstraZeneca Pharmaceuticals LP
$1,439
Gilead Sciences, Inc.
$549
Merck Sharp & Dohme LLC
$171
PUMA BIOTECHNOLOGY, INC.
$37
PFIZER INC.
$36
Tempus AI, Inc
$31
PharmaEssentia USA Corporation
$25
Top 3 companies account for 81.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$149,043
Puma Biotechnology, Inc.
$16,212
TerSera Therapeutics LLC
$13,290
Stemline Therapeutics Inc.
$6,263
Novartis Pharmaceuticals Corporation
$5,097
NOVARTIS PHARMACEUTICALS CORPORATION
$4,518
AstraZeneca Pharmaceuticals LP
$4,403
Eli Lilly and Company
$2,903
Hoffmann-La Roche Limited
$1,763
PFIZER INC.
$1,618
PUMA BIOTECHNOLOGY, INC.
$1,543
Gilead Sciences, Inc.
$1,188
Daiichi Sankyo Inc.
$226
Merck Sharp & Dohme LLC
$171
Clovis Oncology, Inc.
$125
Genentech USA, Inc.
$41
Tempus AI, Inc
$31
PharmaEssentia USA Corporation
$25
ImmunoGen, Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Top 3 companies account for 85.6% of all-time payments
Associated products mentioned in payments ›
BESREMI · CYRAMZA · ENHERTU · Elahere · Enhertu · IBRANCE · KISQALI · NERLYNX · Nerlynx · Non-Covered Product · Orserdu · PIQRAY · Perjeta · Rubraca · Trodelvy · VERZENIO · XT CDX · ZOLADEX · Zoladex · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,628
County median income
$102,285
Nearest hospital to ZIP centroid (approximate)
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McCann is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McCann experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. McCann performed 5,340 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McCann receive payments from pharmaceutical companies?
Yes. Dr. McCann received a total of $208,506 from 20 companies across 381 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCann's costs compare to other internal medicine physicians in San Diego?
Dr. McCann's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in San Diego
Browse internal medicine physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
TerSera Therapeutics LLC Payments to Doctors
See all physicians who received payments from TerSera Therapeutics LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology